Prosecution Insights
Last updated: October 04, 2026

Cardiofocus Inc.

Technology area: Medical Devices & Mechanical Engineering

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Cardiofocus Inc. manages 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are split between 2 distinct examiners and 2 distinct art units. This arrangement indicates that the company's current prosecution activities are spread across different specialized units within the patent office. The use of 2 distinct art units suggests that the applications involve different technical classifications within the medical device sector.

HUH, VYNN V is the busiest examiner for this company, with 1 pending office action currently under review. This 1 action accounts for a portion of the 2 total pending office actions for the portfolio. Because there are 2 distinct examiners for 2 actions, the workload is distributed, with no single examiner handling more than 1 matter. For the practitioner, this means that each pending case requires a unique approach tailored to the specific examiner and art unit involved.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HUH, VYNN V 1 62.2% +44.3%
LANCASTER, LINDSAY REGAN 1 52.9% +20.8%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18622232 LOCAL IMPEDANCE INDICATOR IN THE TREATMENT OF CARDIAC TISSUE HUH, VYNN V —
18243604 DEVICES FOR THE DELIVERY OF PULSED ELECTRIC FIELDS IN THE TREATMENT OF CARDIAC TISSUE LANCASTER, LINDSAY REGAN —

Top Art Units

Art UnitApps
3792 1
3794 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18622232 LOCAL IMPEDANCE INDICATOR IN THE TREATMENT OF CARDIAC TISSUE HUH, VYNN V 3792 §103 Non-Final OA — Pending Mar 29, 2024
18243604 DEVICES FOR THE DELIVERY OF PULSED ELECTRIC FIELDS IN THE TREATMENT OF CARDIAC TISSUE LANCASTER, LINDSAY REGAN 3794 §103 Final Rejection — Pending Sep 07, 2023

Managing Cardiofocus Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month